The significant risk variables for VTE in the derivation obtained based on the univariate analysis included diabetes, ECOG performance status, the use of an erythropoietin-stimulating agent, the use of dexamethasone, and a family history of thrombosis or a history of VTE. This evidence concerns the gene EPO and diabetes mellitus.